Tokenmaxxing, OpenAI’s shopping spree, and the AI Anxiety Gap 

The gap between AI insiders and everyone else is widening, and the spending, suspicion, and even new vocabulary are starting to show it. While OpenAI is busy buying up everything from finance apps to talk shows, a certain shoe company just rebranded as an AI infrastructure play, and Anthropic unveiled a model it says is too powerful to release publicly …but apparently not too… Continua a leggere Tokenmaxxing, OpenAI’s shopping spree, and the AI Anxiety Gap 

Are we tokenmaxxing our way to nowhere?

The gap between AI insiders and everyone else is widening, and the spending, suspicion, and even new vocabulary are starting to show it. While OpenAI is busy buying up everything from finance apps to talk shows, a certain shoe company just rebranded as an AI infrastructure play, and Anthropic unveiled a model it says is too powerful to release publicly …but apparently not too… Continua a leggere Are we tokenmaxxing our way to nowhere?

You’ve heard of hybrid cars. Now meet a hybrid cement plant.

Why choose fossil fuels or electricity when you can have both? NOC Energy has figured out how to hybridize heavy industry.

The musician-turned-biotech-founder waiting to fundraise

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that… Continua a leggere The musician-turned-biotech-founder waiting to fundraise

Airwallex is about to take on Stripe and the rest of the payments industry — in the physical world

Airwallex, valued at $8 billion, is launching a point-of-sale product that lets businesses accept in-person payments in multiple countries via a single platform.

Aloe Blacc’s fame means nothing in biotech (and that’s the point)

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that… Continua a leggere Aloe Blacc’s fame means nothing in biotech (and that’s the point)

This energy startup’s bet on 100-year-old grid tech is paying off

Ayr Energy is using a shortage of power conversion equipment to break open a decades-old market.

Financial risk management platform Pillar raises $20M seed in round led by a16z

Pillar hopes to offer sophisticated, institutional-grade tools to small and medium-sized enterprises. “Our goal is to make hedging as accessible and ubiquitous as payments or accounting software,” he said.

Final 2 days to save up to $500 on your TechCrunch Disrupt 2026 ticket

Ticket discounts of up to $500 will end tomorrow, April 10, at 11:59 p.m. PT. After that, prices for TechCrunch Disrupt 2026 go up again. Miss this, and you’ll be paying more for the same access to one of the most anticipated tech events of the year. Register now to lock in these savings.

This founder helped build SpaceX’s most powerful rocket engine. Now he’s building a ‘fighter jet for orbit.’

The company’s novel rocket engine could be a game changer for the U.S. military.